Podcast
Questions and Answers
What is the physician's primary management for mild symptoms?
What is the physician's primary management for mild symptoms?
- Immediately switching to a high-intensity dose of atorvastatin
- Adding a non-statin lipid-lowering medication
- Holding the statin and challenging once symptoms resolve (correct)
- Reducing the dose of simvastatin to 10mg/day
What is the equivalent dose of atorvastatin to 20mg of simvastatin?
What is the equivalent dose of atorvastatin to 20mg of simvastatin?
- 20mg (correct)
- 80mg
- 10mg
- 40mg
What is the LDL level of the patient in the scenario?
What is the LDL level of the patient in the scenario?
- 150mg/dL
- 195mg/dL (correct)
- 200mg/dL
- 220mg/dL
What is the term for abnormal lipoprotein levels?
What is the term for abnormal lipoprotein levels?
What is the physician's next step after the LDL level is found to be 195mg/dL?
What is the physician's next step after the LDL level is found to be 195mg/dL?
What is the main goal of managing myalgia?
What is the main goal of managing myalgia?
What percentage of bile acid sequants are associated with ovarian syndrome?
What percentage of bile acid sequants are associated with ovarian syndrome?
Why is the physician avoiding drug interactions?
Why is the physician avoiding drug interactions?
Which of the following conditions is not associated with dyslipidemias?
Which of the following conditions is not associated with dyslipidemias?
What is the reason for not using simvastatin 80mg/day?
What is the reason for not using simvastatin 80mg/day?
What is the primary cause of primary dyslipidemias?
What is the primary cause of primary dyslipidemias?
What is the primary reason for drawing an cholesterol panel?
What is the primary reason for drawing an cholesterol panel?
Which of the following is a secondary cause of dyslipidemias?
Which of the following is a secondary cause of dyslipidemias?
What is the term for a group of symptoms associated with kidney disease?
What is the term for a group of symptoms associated with kidney disease?
Which of the following is not a condition associated with dyslipidemias?
Which of the following is not a condition associated with dyslipidemias?
What is the term for abnormal lipoprotein levels caused by lifestyle or medical conditions?
What is the term for abnormal lipoprotein levels caused by lifestyle or medical conditions?
What is the primary consideration for a patient with a very high-risk and LDL remaining at 70mg/dL?
What is the primary consideration for a patient with a very high-risk and LDL remaining at 70mg/dL?
What is the mechanism of action of ezetimibe in reducing cholesterol levels?
What is the mechanism of action of ezetimibe in reducing cholesterol levels?
What is the criteria for a patient to be considered high-risk?
What is the criteria for a patient to be considered high-risk?
What is the target LDL level for a patient with primary hypercholesterolemia and statin at max dose?
What is the target LDL level for a patient with primary hypercholesterolemia and statin at max dose?
What is the alternative treatment option for a patient with LDL remaining at 100mg/dL despite statin at max dose?
What is the alternative treatment option for a patient with LDL remaining at 100mg/dL despite statin at max dose?
What is the characteristic of a patient who would benefit from PCSK9 inhibitors?
What is the characteristic of a patient who would benefit from PCSK9 inhibitors?
What is the primary limitation of using barley and oat bran extracts in cholesterol synthesis?
What is the primary limitation of using barley and oat bran extracts in cholesterol synthesis?
What is the recommended statin treatment intensity for patients with clinical ASCVD?
What is the recommended statin treatment intensity for patients with clinical ASCVD?
What is the primary goal of statin treatment in patients with dyslipidemia?
What is the primary goal of statin treatment in patients with dyslipidemia?
What is the recommended statin treatment intensity for patients with LDL > 190 mg/dL?
What is the recommended statin treatment intensity for patients with LDL > 190 mg/dL?
What is the definition of high-intensity statin treatment?
What is the definition of high-intensity statin treatment?
What is the recommended statin treatment intensity for patients with diabetes and LDL between 70-189 mg/dL?
What is the recommended statin treatment intensity for patients with diabetes and LDL between 70-189 mg/dL?
What is the primary factor in determining statin treatment intensity?
What is the primary factor in determining statin treatment intensity?
What is the recommended statin treatment intensity for patients with a 10-year ASCVD risk > 20%?
What is the recommended statin treatment intensity for patients with a 10-year ASCVD risk > 20%?
What is the definition of moderate-intensity statin treatment?
What is the definition of moderate-intensity statin treatment?
What is the recommended statin treatment intensity for patients with a 10-year ASCVD risk between 7.5-19.9%?
What is the recommended statin treatment intensity for patients with a 10-year ASCVD risk between 7.5-19.9%?
What is the primary contraindication for fenofibrate in patients with liver disease?
What is the primary contraindication for fenofibrate in patients with liver disease?
What is the recommended dosage of fenofibric acid for treating hypertriglyceridemia?
What is the recommended dosage of fenofibric acid for treating hypertriglyceridemia?
What is a common side effect of gemfibrozil?
What is a common side effect of gemfibrozil?
What is the recommended dosage of Triglide for treating hypertriglyceridemia?
What is the recommended dosage of Triglide for treating hypertriglyceridemia?
What is the recommended dosage of Lipofen for treating hypertriglyceridemia?
What is the recommended dosage of Lipofen for treating hypertriglyceridemia?
What is a contraindication for fenofibrate in patients with kidney disease?
What is a contraindication for fenofibrate in patients with kidney disease?
What is the recommended dosage of fenofibrate for treating hypertriglyceridemia?
What is the recommended dosage of fenofibrate for treating hypertriglyceridemia?
What is a common side effect of fenofibrate?
What is a common side effect of fenofibrate?
What is the recommended dosage of gemfibrozil for treating hypertriglyceridemia?
What is the recommended dosage of gemfibrozil for treating hypertriglyceridemia?
What is the effect of fibrate on lipid levels?
What is the effect of fibrate on lipid levels?
Study Notes
Classification of Dyslipidemia
- Dyslipidemia is a condition characterized by abnormal lipoprotein levels
- Can be classified as primary (genetic cause) or secondary (due to lifestyle and/or medical conditions)
- Abnormal lipoprotein levels can lead to liver disease, nephrotic syndrome, and other conditions
Conditions Associated with Dyslipidemia
- Anorexia
- Obesity
- Poor diet
- Hypothyroidism
- Alcoholism
- Smoking
- Diabetes
- Renal disease
Statin Treatment Intensity
- Determining statin treatment intensity is based on patient risk
- High-intensity statin treatment is recommended for patients with a high risk of ASCVD (Atherosclerotic Cardiovascular Disease)
- Moderate-intensity statin treatment is recommended for patients with a moderate risk of ASCVD
- Low-intensity statin treatment is recommended for patients with a low risk of ASCVD
Statin Benefit Groups
- Secondary prevention: patients with clinical ASCVD
- Primary prevention: patients with a high risk of ASCVD
- Patients with diabetes and ages 40-75 years with LDL > 190 mg/dL
- Patients with a 10-year ASCVD risk > 20%
Statin Treatment Options
- Atorvastatin: high-intensity (40-80 mg) and moderate-intensity (10-20 mg) options
- Rosuvastatin: high-intensity (20-40 mg) and moderate-intensity (5-10 mg) options
- Simvastatin: high-intensity (40-80 mg) and moderate-intensity (20-40 mg) options
- Pravastatin: moderate-intensity (40-80 mg) option
- Lovastatin: moderate-intensity (40-80 mg) option
- Fluvastatin: low-intensity (20-40 mg) option
- Pitavastatin: low-intensity (2-4 mg) option
Non-Statins Treatment Options
- Ezetimibe: preferred for patients with a high risk of ASCVD and LDL remains > 70 mg/dL
- PCSK9 Inhibitors: recommended for patients with a high risk of ASCVD and LDL remains > 70 mg/dL
- Fenofibrate: recommended for patients with primary hypercholesterolemia (LDL > 190 mg/dL) and LDL remains > 100 mg/dL
Fibrate Drug Interactions
- Fenofibrate: can be used with caution in patients with renal disease and gallbladder disease
- Gemfibrozil: can increase the risk of myopathy when used with statins, especially in the elderly, diabetes, and renal failure
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz covers the basics of bile acid sequents, its relation to anorexia, and other conditions associated with it. Test your knowledge of the medical concepts and their connections.